Update on cardiac sarcoidosis.
Cardiac magnetic resonance imaging
Cardiac sarcoidosis
Sarcoidosis
Ventricular tachycardia
Journal
Trends in cardiovascular medicine
ISSN: 1873-2615
Titre abrégé: Trends Cardiovasc Med
Pays: United States
ID NLM: 9108337
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
16
12
2021
revised:
20
04
2022
accepted:
27
04
2022
medline:
23
10
2023
pubmed:
4
5
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
Cardiac sarcoidosis is an inflammatory myocardial disease of unknown etiology. It is characterized by the deposition of non-caseating granulomas that may involve any part of the heart. Cardiac sarcoidosis is often under-diagnosed or recognized partly due to the heterogeneous clinical presentation of the disease. The three most frequent clinical manifestations of cardiac sarcoidosis are atrioventricular block, ventricular arrhythmias, and heart failure. A definitive diagnosis of cardiac sarcoidosis can be made with histology findings from an endomyocardial biopsy. However, the diagnosis in the majority of cases is based on findings from the clinical presentation and advanced imaging due to the low sensitivity of endomyocardial biopsy. The Heart Rhythm Society (HRS) 2014 expert consensus statement and the Japanese Ministry of Health and Welfare criteria are the two most commonly used diagnostic criteria sets. This review article summarizes the available evidence on cardiac sarcoidosis, focusing on the diagnostic criteria and stepwise approach to its management.
Identifiants
pubmed: 35504422
pii: S1050-1738(22)00066-4
doi: 10.1016/j.tcm.2022.04.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
442-455Informations de copyright
Copyright © 2022. Published by Elsevier Inc.